Resources
-
Evaluating the Impact of Analytical Method Parameters on Therapeutic mRNA Integrity by Capillary Gel Electrophoresis
Speaker Presentation: CE Pharm 2025
Lu Huixin, Health Canada, 2025 -
Charge Heterogeneity Analysis of Antibody Drug Conjugates: Capillary Zone Electrophoresis
Speaker Presentation: CE Pharm 2025
Linkous Rick, AstraZeneca, 2025 -
Improving ADC Sample Stability in icIEF by Altering Separation Matrix pH a Case Study
Speaker Presentation: CE Pharm 2025
Li Huiyuan, Bristol-Myers Squibb Company, 2025 -
Design of a Capillary Isoelectric Focusing Electrospray Ionization-Mass Spectrometry Interface for High Resolution Proteoform Analysis
Speaker Presentation: CE Pharm 2025
Kerr Caitlin, Bristol-Myers Squibb Company, 2025 -
A Novel Derivatization-Based CGE Assay for Quantifying Free Proteins in Conjugate Vaccines
Speaker Presentation: CE Pharm 2025
Huang Haofu, Merck & Co., Inc., 2025 -
Development and Optimization of a CGE-LIF Method for RNA Integrity Characterization using SCIEX 9000 RNA Kit
Speaker Presentation: CE Pharm 2025
Cozzens Yuqing, Pfizer, Inc., 2025 -
What Is the Future of Belonging in the Workplace
Roundtable Notes: Session 1 Table 10 CE Pharm 2025
What Is the Future of Belonging in the Workplace -
Technology Advancements in CE [Session 2]
Roundtable Notes: Session 2 Table 4 CE Pharm 2025
Technology Advancements in CE -
Technology Advancements in CE
Roundtable Notes: Session 1 Table 4 CE Pharm 2025
Technology Advancements in CE -
Strategies and Qualification of Critical Reagents
Roundtable Notes: Session 1 Table 7 CE Pharm 2025
Strategies and Qualification of Critical Reagents -
Strategies and Challenges with Peak Integration in CE [Session 2]
Roundtable Notes: Session 2 Table 1 CE Pharm 2025
Strategies and Challenges with Peak Integration in CE -
Strategies and Challenges with Peak Integration in CE
Roundtable Notes: Session 1 Table 1 CE Pharm 2025
Strategies and Challenges with Peak Integration in CE -
SDS-CGE and CGE Method Development and Application
Roundtable Notes: Session 2 Table 8 CE Pharm 2025
SDS-CGE and CGE Method Development and Application -
mRNA Vaccine CE Applications [Session 2]
Roundtable Notes: Session 2 Table 5 CE Pharm 2025
mRNA Vaccine CE Applications -
mRNA Vaccine CE Applications
Roundtable Notes: Session 1 Table 5 CE Pharm 2025
mRNA Vaccine CE Applications -
Managing Critical Reagents for Capillary Electrophoresis Methods
Roundtable Notes: Session 1 Table 9 CE Pharm 2025
Managing Critical Reagents for Capillary Electrophoresis Methods -
ICH Q2 R2 and CE
Roundtable Notes: Session 1 Table 8 CE Pharm 2025
ICH Q2 R2 and CE -
How Fast Can We Go Without Sacrificing Quality
Roundtable Notes: Session 2 Table 7 CE Pharm 2025
How Fast Can We Go Without Sacrificing Quality -
Forgotten CE Technologies - CGE, ITP, Affinity CE, Taylor Dispersion
Roundtable Notes: Session 1 Table 6 CE Pharm 2025
Forgotten CE Technologies - CGE, ITP, Affinity CE, Taylor Dispersion -
Empowering a Speak Up Culture in the Biopharmaceutical Industry - Promoting Psychological Safety
Roundtable Notes: Session 2 Table 10 CE Pharm 2025
Empowering a Speak Up Culture in the Biopharmaceutical Industry - Promoting Psychological Safety